TXNIP and neoplasm: Subsequently, T cell killing in response to HLA-A2+ A375 tumor cells presenting NY-ESO-1 was compared between NT (non-transduced), NY WT (TCR only) and NY KO (TCR with TXNIP KO) T cells.